SRF expects better Q4 for specialty chemicals biz. But is that enough?
Subscribe to enjoy similar stories. SRF Ltd’s shares fell 8% in the past two trading sessions as weaker-than-anticipated December quarter (Q3FY26) results triggered earnings downgrades by various brokerages. Consolidated revenue at ₹3,713 crore missed consensus estimate of ₹3,800 crore.
Ebitda at ₹780 crore was much lower than the consensus estimate of ₹820 crore. The problem is that SRF’s chemicals business (49% of Q3 revenue mix) has been a story of two halves lately. The chemicals business comprises fluorochemicals and specialty chemicals.
Fluorochemicals delivered a solid performance in Q3 with higher realizations and increased volumes of hydrofluorocarbon (HFC) refrigerants. The outlook is upbeat as global HFC prices have been firm; the management is also seeing recovery in domestic demand after a weak first half (H1FY26) due to prolonged monsoons. On the other hand, specialty chemicals remained a drag as growth was marred by aggressive Chinese pricing, which led to increased margin pressure and deferred offtake by key customers.
SRF expects the specialty chemicals business to be relatively better in Q4, led by strong volume-led recovery, aided by pent-up demand. It also expects raw material prices to be softer. That said, the management indicated that it may not be able to meet its earlier 20% specialty chemicals sales growth guidance for FY26.
This seems to have spooked investors. After all, specialty chemicals share in chemical business revenue mix was 57% in FY26 and is estimated to be at 56% in FY26, as per JM Financial Institutional Securities. A concern is that one quarter of bounce-back in the specialty chemicals business may not substantially alter earnings growth expectations, and sustainable recovery
. Read on livemint.com